Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors.

Webster JD, Kiupel M, Yuzbasiyan-Gurkan V.

BMC Cancer. 2006 Apr 1;6:85.

2.

The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.

Webster JD, Yuzbasiyan-Gurkan V, Kaneene JB, Miller R, Resau JH, Kiupel M.

Neoplasia. 2006 Feb;8(2):104-11.

3.

Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs.

Downing S, Chien MB, Kass PH, Moore PE, London CA.

Am J Vet Res. 2002 Dec;63(12):1718-23.

PMID:
12492288
4.

The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.

Kiupel M, Webster JD, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V.

Vet Pathol. 2004 Jul;41(4):371-7. Erratum in: Vet Pathol. 2004 Sep;41(5):543.

PMID:
15232137
5.

Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms.

Ma Y, Longley BJ, Wang X, Blount JL, Langley K, Caughey GH.

J Invest Dermatol. 1999 Feb;112(2):165-70.

6.

Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.

Webster JD, Yuzbasiyan-Gurkan V, Miller RA, Kaneene JB, Kiupel M.

Vet Pathol. 2007 May;44(3):298-308.

PMID:
17491070
7.

Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors.

Pryer NK, Lee LB, Zadovaskaya R, Yu X, Sukbuntherng J, Cherrington JM, London CA.

Clin Cancer Res. 2003 Nov 15;9(15):5729-34.

8.

Tandem duplication of KIT exon 11 influences the proteome of canine mast cell tumours.

Schlieben P, Meyer A, Weise C, Bondzio A, Gruber AD, Klopfleisch R.

J Comp Pathol. 2013 May;148(4):318-22. doi: 10.1016/j.jcpa.2012.07.006. Epub 2012 Aug 27.

PMID:
22935087
9.

Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit.

London CA, Galli SJ, Yuuki T, Hu ZQ, Helfand SC, Geissler EN.

Exp Hematol. 1999 Apr;27(4):689-97.

PMID:
10210327
10.

Detection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis.

Jones CL, Grahn RA, Chien MB, Lyons LA, London CA.

J Vet Diagn Invest. 2004 Mar;16(2):95-100.

PMID:
15053358
11.
12.

Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11.

Gregory-Bryson E, Bartlett E, Kiupel M, Hayes S, Yuzbasiyan-Gurkan V.

BMC Cancer. 2010 Oct 15;10:559. doi: 10.1186/1471-2407-10-559.

13.

Concordance of c-kit mutational status in matched primary and metastatic cutaneous canine mast cell tumors at baseline.

Marconato L, Zorzan E, Giantin M, Di Palma S, Cancedda S, Dacasto M.

J Vet Intern Med. 2014 Mar-Apr;28(2):547-53. doi: 10.1111/jvim.12266. Epub 2013 Dec 26.

14.

c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.

Giantin M, Vascellari M, Morello EM, Capello K, Vercelli A, Granato A, Lopparelli RM, Nassuato C, Carminato A, Martano M, Mutinelli F, Dacasto M.

J Vet Diagn Invest. 2012 Jan;24(1):116-26. doi: 10.1177/1040638711425945. Epub 2011 Dec 6.

15.

Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.

Takeuchi Y, Fujino Y, Watanabe M, Takahashi M, Nakagawa T, Takeuchi A, Bonkobara M, Kobayashi T, Ohno K, Uchida K, Asano K, Nishimura R, Nakayama H, Sugano S, Ohashi Y, Tsujimoto H.

Vet J. 2013 Jun;196(3):492-8. doi: 10.1016/j.tvjl.2012.11.018. Epub 2013 Feb 4.

PMID:
23384436
16.

Canine mast cell tumors express stem cell factor receptor.

Reguera MJ, Rabanal RM, Puigdemont A, Ferrer L.

Am J Dermatopathol. 2000 Feb;22(1):49-54.

PMID:
10698217
17.

Use of kit internal tandem duplications to establish mast cell tumor clonality in 2 dogs.

Zavodovskaya R, Chien MB, London CA.

J Vet Intern Med. 2004 Nov-Dec;18(6):915-7.

18.

All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.

Meyer A, Gruber AD, Klopfleisch R.

J Comp Pathol. 2013 Jul;149(1):19-29. doi: 10.1016/j.jcpa.2012.11.232. Epub 2012 Dec 28.

PMID:
23276382
19.

Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs.

Zemke D, Yamini B, Yuzbasiyan-Gurkan V.

Vet Pathol. 2002 Sep;39(5):529-35.

PMID:
12243462
20.

Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.

Preziosi R, Morini M, Sarli G.

J Vet Diagn Invest. 2004 Nov;16(6):554-61.

PMID:
15586571

Supplemental Content

Support Center